Insufficient Evidence of Clinical Validity and Utility for the Majority of ctDNA Assays in Advanced Cancer

Robust research is needed in several areas to enable development of clinical practice recommendations

Read full article (External website)

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply